Literature DB >> 16266985

HIN-1, an inhibitor of cell growth, invasion, and AKT activation.

Ian Krop1, Michele Taylor Parker, Noga Bloushtain-Qimron, Dale Porter, Rebecca Gelman, Hidefumi Sasaki, Matthew Maurer, Mary Beth Terry, Ramon Parsons, Kornelia Polyak.   

Abstract

The HIN-1 gene encoding a small, secreted protein is silenced due to methylation in a substantial fraction of breast, prostate, lung, and pancreatic carcinomas, suggesting a potential tumor suppressor function. The receptor of HIN-1 is unknown, but ligand-binding studies indicate the presence of high-affinity cell surface HIN-1 binding on epithelial cells. Here, we report that HIN-1 is a potent inhibitor of anchorage-dependent and anchorage-independent cell growth, cell migration, and invasion. Expression of HIN-1 in synchronized cells inhibits cell cycle reentry and the phosphorylation of the retinoblastoma protein (Rb), whereas in exponentially growing cells, HIN-1 induces apoptosis without apparent cell cycle arrest and effect on Rb phosphorylation. Investigation of multiple signaling pathways revealed that mitogen-induced phosphorylation and activation of AKT are inhibited in HIN-1-expressing cells. In addition, expression of constitutively activate AKT abrogates HIN-1-mediated growth arrest. Taken together, these studies provide further evidence that HIN-1 possesses tumor suppressor functions, and that these activities may be mediated through the AKT signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16266985     DOI: 10.1158/0008-5472.CAN-05-1663

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  32 in total

1.  Silence of HIN-1 expression through methylation of its gene promoter in gastric cancer.

Authors:  Yan Gong; Ming-Zhou Guo; Zhi-Jia Ye; Xiu-Li Zhang; Yong-Liang Zhao; Yun-Sheng Yang
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

Review 2.  The epigenetics of breast cancer.

Authors:  Jovana Jovanovic; Jo Anders Rønneberg; Jörg Tost; Vessela Kristensen
Journal:  Mol Oncol       Date:  2010-04-29       Impact factor: 6.603

Review 3.  Dietary fat and obesity as modulators of breast cancer risk: Focus on DNA methylation.

Authors:  Micah G Donovan; Spencer N Wren; Mikia Cenker; Ornella I Selmin; Donato F Romagnolo
Journal:  Br J Pharmacol       Date:  2020-01-26       Impact factor: 8.739

4.  Investigation of SCGB3A1 (UGRP2) gene arrays in patients with nasal polyposis.

Authors:  Mehmet Palalı; K Murat Özcan; Sibel Ozdaş; Sabri Köseoğlu; Talih Ozdaş; Selim S Erbek; Erol Yıldırım; Serdar Ensari; Hüseyin Dere
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-08       Impact factor: 2.503

5.  Secretoglobin 3A2/uteroglobin-related protein 1 is a novel marker for pulmonary carcinoma in mice and humans.

Authors:  Reiko Kurotani; Nobue Kumaki; Xu Naizhen; Jerrold M Ward; R Ilona Linnoila; Shioko Kimura
Journal:  Lung Cancer       Date:  2010-05-13       Impact factor: 5.705

Review 6.  Novel insights into the molecular origins and treatment of lung cancer.

Authors:  James D Webb; M Celeste Simon
Journal:  Cell Cycle       Date:  2010-10-11       Impact factor: 4.534

7.  Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.

Authors:  Qiwei Yang; Yufeng Tian; Kelly R Ostler; Alexandre Chlenski; Lisa J Guerrero; Helen R Salwen; Lucy A Godley; Susan L Cohn
Journal:  BMC Cancer       Date:  2010-06-14       Impact factor: 4.430

8.  HIN-1: a New Epigenetic Biomarker Crucial for Therapy Selection in Glioblastoma Multiforme.

Authors:  M Herranz; M E Padín-Iruegas; Nieves Martínez-Lago; S Aguín Losada; P Raña-Díez; E Brozos Vázquez; J J Carrera; J R Antúnez; A Ruibal; R López-López
Journal:  Mol Neurobiol       Date:  2015-03-11       Impact factor: 5.590

9.  HIF-1alpha and HIF-2alpha have divergent roles in colon cancer.

Authors:  Takaaki Imamura; Hirotoshi Kikuchi; Maria-Teresa Herraiz; Do-Youn Park; Yusuke Mizukami; Mari Mino-Kenduson; Maureen P Lynch; Bo R Rueda; Yair Benita; Ramnik J Xavier; Daniel C Chung
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

10.  Valproic acid shows a potent antitumor effect with alteration of DNA methylation in neuroblastoma.

Authors:  Song Gu; Yufeng Tian; Alexandre Chlenski; Helen R Salwen; Ziyan Lu; J Usha Raj; Qiwei Yang
Journal:  Anticancer Drugs       Date:  2012-11       Impact factor: 2.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.